Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GDXJ vs GSK✓SelectedUSD · GSKGDXJ vs GSK performance historyLatest closeAs of-5.32%11/20
Stock and ETF performance explorer

GDXJ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.9%
GSK return
+53.4%
Excess return
+94.6%
Maximum drawdown
-48.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.3%-0.1%-5.2%-5.3%
7D-17.9%-5.3%-12.6%-17.1%
30D-25.1%-3.7%-21.5%-24.6%
3M-37.1%-7.3%-29.8%-36.2%
6M-28.3%-4.2%-24.1%-27.8%
YTD-28.6%+0.9%-29.4%-28.4%
1Y-11.0%+7.3%-18.3%-11.7%
3Y+147.9%+52.7%+95.2%+109.8%
All+147.9%+53.4%+94.6%+109.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling